Cargando…
PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
Among cardiovascular diseases, atherosclerosis remains the first cause of death in the United States of America and Europe, as it leads to myocardial infarction or stroke. The high prevalence of heart diseases is due to the difficulty in diagnosing atherosclerosis, since it can develop for decades b...
Autores principales: | Giacalone, Giovanna, Tsapis, Nicolas, Mousnier, Ludivine, Chacun, Hélène, Fattal, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213468/ https://www.ncbi.nlm.nih.gov/pubmed/30262751 http://dx.doi.org/10.3390/ma11101845 |
Ejemplares similares
-
Improving dexamethasone drug loading and efficacy in treating arthritis through a lipophilic prodrug entrapped into PLGA-PEG nanoparticles
por: Simón-Vázquez, Rosana, et al.
Publicado: (2022) -
Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016) -
The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018) -
Rosiglitazone and Fenofibrate Additive Effects on Lipids
por: Slim, Ahmad, et al.
Publicado: (2011) -
Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011)